liu.seSearch for publications in DiVA
Change search
Link to record
Permanent link

Direct link
BETA
Cheung, Kwan Yee
Alternative names
Publications (5 of 5) Show all publications
Mousavisani, S. Z., Raoof, J.-B., Cheung, K. Y., Hernandez Camargo, A. R., Ruzgas, T., Turner, A. & Mak, W. C. (2019). Integrating an ex-vivo skin biointerface with electrochemical DNA biosensor for direct measurement of the protective effect of UV blocking agents. Biosensors & bioelectronics, 128, 159-165
Open this publication in new window or tab >>Integrating an ex-vivo skin biointerface with electrochemical DNA biosensor for direct measurement of the protective effect of UV blocking agents
Show others...
2019 (English)In: Biosensors & bioelectronics, ISSN 0956-5663, E-ISSN 1873-4235, Vol. 128, p. 159-165Article in journal (Refereed) Published
Abstract [en]

Skin cancer is the most frequent kind of cancer in white people in many parts of the world. UV-induced DNA damage and genetic mutation can subsequently lead to skin cancer. Therefore development of new biosensing strategies for detection of UV-induced DNA damage is of great importance. Here we demonstrate a novel combination of an ex-vivo skin biointerface and an electrochemical DNA sensor for the direct detection of UV-induced DNA damage and investigation the protective effect of various UV blockers (Zinc-oxide (ZnO), titanium dioxide (TiO2) nanoparticles (NPs) and sunscreens) against DNA damage. A diazonium modified screen-printed carbon electrode immobilized with a DNA sequence related to the p53 tumour suppressor gene, the most commonly affected gene in human UV-induced skin cancer, was applied as an electrochemical DNA sensor. Electrochemical impedance spectroscopy (EIS) was employed for the detection of DNA damage induced by UV-A radiation by following the changes in charge transfer resistance (R-ct). The protective effects of UV blockers applied onto a pig skin surface (a suitable model representing human skin) were successfully detected by the DNA sensor. We observed that the naked skin has little UV protection showing an 18.2% decreases in Delta R/R values compared to the control, while applying both NPs and NP-formulated sunscreens could significantly reduce DNA damage, resulting in a decrease in Delta R/R values of 67.1% (ZnO NPs), 77.2% (TiO2 NPs), 77.1% (sunscreen 1) and 92.4% (sunscreen 2), respectively. Moreover, doping moisturising cream with NPs could provide a similar DNA protective effect. This new method is a biologically relevant alternative to animal testing and offers advantages such as fast, easy and inexpensive processing, in addition to its miniaturised dimension, and could be used for a range of applications in other sources of DNA damage and the protective effect of different UV blocking agents and other topical formulations.

Place, publisher, year, edition, pages
Elsevier, 2019
Keywords
Skin biointerface; Electrochemical DNA biosensor; DNA damage; Nanoparticles; Sunscreens
National Category
Analytical Chemistry
Identifiers
urn:nbn:se:liu:diva-154535 (URN)10.1016/j.bios.2018.12.025 (DOI)000457950200022 ()30660931 (PubMedID)2-s2.0-85060007471 (Scopus ID)
Note

Funding Agencies|Knowledge Foundation [20140211, 20170058]; The Gustav Th. Ohlssons Fond

Available from: 2019-02-20 Created: 2019-02-20 Last updated: 2019-02-28Bibliographically approved
Ghani, M., Mak, W. C., Cheung, K. Y., Montazer, M., Rezaei, B. & Griffith, M. (2016). Cross-linked superfine electrospun tragacanth-based biomaterial as scaffolds for tissue engineering. Paper presented at eCM Meeting Abstracts 2016, Collection 1, Towards Future Regenerative Therapies TERMIS-EU 2016 Conference, June 28 - July 1, Uppsala, Sweden. European Cells and Materials, 31(Suppl. 1), 204-204
Open this publication in new window or tab >>Cross-linked superfine electrospun tragacanth-based biomaterial as scaffolds for tissue engineering
Show others...
2016 (English)In: European Cells and Materials, ISSN 1473-2262, E-ISSN 1473-2262, Vol. 31, no Suppl. 1, p. 204-204Article in journal, Meeting abstract (Refereed) Published
Abstract [en]

Natural polymer-based nanofibrous structures promote cell adhesion and proliferation due to their high surface area/volume ratio, high porosity, and similarity to native extracellular matrix in terms of both chemical composition and physical structure. Gum tragacanth (Tg) is a natural polysaccharides obtained from plants. It is a biocompatible, biodegradable and anionic polysaccharides that has been used extensively as an emulsifier in food and pharmaceutical industries. Despite, its good rheological properties and compatibility, the potential biomedical applications of Tg have not been fully investigated. The objective of the present study was to explore the feasibility of combining Tg with gelatin to fabricate a scaffold that serves as a simple collagen-glycosaminoglycans analog for tissue engineering applications, e.g. as a scaffold for human skin epithelial cells.

Place, publisher, year, edition, pages
Davos, Switzerland: AO Research Institute Davos, 2016
National Category
Nano Technology
Identifiers
urn:nbn:se:liu:diva-151904 (URN)
Conference
eCM Meeting Abstracts 2016, Collection 1, Towards Future Regenerative Therapies TERMIS-EU 2016 Conference, June 28 - July 1, Uppsala, Sweden
Available from: 2018-10-09 Created: 2018-10-09 Last updated: 2018-10-19Bibliographically approved
Lademann, J., Richter, H., Knorr, F., Patzelt, A., Darvin, M. E., Ruehl, E., . . . Mak, W. C. (2016). Triggered release of model drug from AuNP-doped BSA nanocarriers in hair follicles using IRA radiation. Acta Biomaterialia, 30, 388-396
Open this publication in new window or tab >>Triggered release of model drug from AuNP-doped BSA nanocarriers in hair follicles using IRA radiation
Show others...
2016 (English)In: Acta Biomaterialia, ISSN 1742-7061, E-ISSN 1878-7568, Vol. 30, p. 388-396Article in journal (Refereed) Published
Abstract [en]

Recent advances in the field of dermatotherapy have resulted in research efforts focusing on the use of particle-based drug delivery systems for the stimuli-responsive release of drugs in the skin and skin appendages, i.e. hair follicles and sebaceous glands. However, effective and innocuous trigger mechanisms which result in the release of the drugs from the nanocarriers upon reaching the target structures are still lacking. For the first time, the present study demonstrated the photo-activated release of the model drug fluorescein isothiocyanate (FITC) from topically applied gold nanoparticle-doped bovine serum albumin (AuNPs-doped BSA) particles (approx. 545 nm) using water-filtered infrared A (IRA) radiation in the hair follicles of an ex vivo porcine skin model. The IRA radiation-induced plasmonic heating of the AuNPs results in the partial decomposition or opening of the albumin particles and release the model drug, while control particles without AuNPs show insignificant release. The results demonstrate the feasibility of using IRA radiation to induce release of encapsulated drugs from plasmonic nanocarriers for the targeting of follicular structures. However, the risk of radiation-induced skin damage subsequent to repeated applications of high infrared dosages may be significant. Future studies should aim at determining the suitability of lower infrared A dosages, such as for medical treatment regimens which may necessitate repeated exposure to therapeutics. Statement of significance Follicular targeting using nanocarriers is of increasing importance in the prophylaxis and treatment of dermatological or other diseases. For the first time, the present study demonstrated the photo activated release of the model drug fluorescein isothiocyanate (FITC) from topically applied gold nanoparticle-doped bovine serum albumin (AuNPs-doped BSA) particles using water-filtered infrared A (IRA) radiation in the hair follicles of an ex vivo porcine skin model. The results demonstrate the feasibility of using wIRA radiation to induce release of encapsulated drugs for the targeting of follicular structures, and provide a new vision on the development of optically addressable delivery systems for controlled release of drugs in the skin and skin appendages, i.e. hair follicles and sebaceous glands. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Place, publisher, year, edition, pages
ELSEVIER SCI LTD, 2016
Keywords
Hair follicles; Nanoparticles; Triggered drug release; IRA radiation; Plasmonic resonance
National Category
Other Chemistry Topics
Identifiers
urn:nbn:se:liu:diva-125152 (URN)10.1016/j.actbio.2015.11.052 (DOI)000368563600035 ()26621698 (PubMedID)
Note

Funding Agencies|Collaborative Research Centre of the German Research Foundation [1112]

Available from: 2016-02-15 Created: 2016-02-15 Last updated: 2017-04-26
Cheung Mak, W., Kwan Yee, C., Orban, J., Lee, C.-J., Turner, A. & Griffith, M. (2015). Surface-Engineered Contact Lens as an Advanced Theranostic Platform for Modulation and Detection of Viral Infection. ACS Applied Materials and Interfaces, 7(45), 25487-25494
Open this publication in new window or tab >>Surface-Engineered Contact Lens as an Advanced Theranostic Platform for Modulation and Detection of Viral Infection
Show others...
2015 (English)In: ACS Applied Materials and Interfaces, ISSN 1944-8244, E-ISSN 1944-8252, Vol. 7, no 45, p. 25487-25494Article in journal (Refereed) Published
Abstract [en]

We have demonstrated an entirely new concept of a wearable theranostic device in the form of a contact lens (theranostic lens) with a dual-functional hybrid surface to modulate and detect a pathogenic attack, using a the corneal HSV serotype-1 (HSV-1) model. The theranostic lenses were constructed using a facile layer-by-layer surface engineering technique, keeping the theranostic lenses with good surface wettability, optically transparency, and nontoxic toward human corneal epithelial cells. The theranostic lenses were used to capture and concentrate inflammatory cytokines such as interleukin-1 alpha (IL-1 alpha), which is upregulated during HSV-1 reactivation, for sensitive, noninvasive diagnostics. The theranostic lens also incorporated an antiviral coating to serve as a first line of defense to protect patients against disease. Our strategy tackles major problems in tear diagnostics that are mainly associated with the sampling of a relatively small volume of fluid and the low concentration of biomarkers. The theranostic lenses show effective anti-HSV-1 activity and good analytical performance for the detection of IL-1a, with a limit of detection of 1.43 pg mL(-1) and a wide linear range covering the clinically relevant region. This work offers a new paradigm for wearable noninvasive healthcare devices combining diagnosis and protection against disease, while supporting patient compliance. We believe that this approach holds immense promise as a next-generation point-of-care and decentralized diagnostic/theranostic platform for a range of biomarkers.

Place, publisher, year, edition, pages
American Chemical Society (ACS), 2015
Keywords
theranostics; contact lens; cornea; antiviral; diagnostics
National Category
Biological Sciences Clinical Medicine Physical Sciences
Identifiers
urn:nbn:se:liu:diva-123520 (URN)10.1021/acsami.5b08644 (DOI)000365148600060 ()26512953 (PubMedID)
Note

Funding Agencies|Linkoping Center for Life Science Technologies; Swedish Research Council [521-2012-5706]

Available from: 2015-12-22 Created: 2015-12-21 Last updated: 2017-12-01
Chan, C. P., Mak, W. C., Cheung, K. Y., Sin, K. K., Yu, C. M., Rainer, T. H. & Renneberg, R. (2013). Evidence-Based Point-of-Care Diagnostics: Current Status and Emerging Technologies. Annual Review of Analytical Chemistry, 6, 191-211
Open this publication in new window or tab >>Evidence-Based Point-of-Care Diagnostics: Current Status and Emerging Technologies
Show others...
2013 (English)In: Annual Review of Analytical Chemistry, ISSN 1936-1327, Vol. 6, p. 191-211Article in journal (Refereed) Published
Abstract [en]

Point-of-care (POC) diagnostics brings tests nearer to the site of patient care. The turnaround time is short, and minimal manual interference enables quick clinical management decisions. Growth in POC diagnostics is being continuously fueled by the global burden of cardiovascular and infectious diseases. Early diagnosis and rapid initiation of treatment are crucial in the management of such patients. This review provides the rationale for the use of POC tests in acute coronary syndrome, heart failure, human immunodeficiency virus, and tuberculosis. We also consider emerging technologies that are based on advanced nanomaterials and microfluidics, improved assay sensitivity, miniaturization in device design, reduced costs, and high-throughput multiplex detection, all of which may shape the future development of POC diagnostics.

Place, publisher, year, edition, pages
Annual Reviews, 2013
Keywords
acute coronary syndrome, heart failure, human immunodeficiency virus, microfluidics, POC, tuberculosis
National Category
Engineering and Technology
Identifiers
urn:nbn:se:liu:diva-98228 (URN)10.1146/annurev-anchem-062012-092641 (DOI)000323887500010 ()978-0-8243-4406-1 (ISBN)
Note

ISBN: 978-0-8243-4406-1

Available from: 2013-10-03 Created: 2013-10-03 Last updated: 2016-09-01Bibliographically approved
Organisations

Search in DiVA

Show all publications